Health Care/Hospital

World's 1st inactivated COVID-19 vaccine produces antibodies

BEIJING, June 24, 2020 /PRNewswire/ -- A news report by Qu Jian from Science and Technology Daily: The Phase I/II clinical trials of the world's first inactivated COVID-19 vaccine, developed by Wuhan Institute of Biological Products under the China National Biotec Group (CNBG) affiliated to the ...

2020-06-24 11:07 736

InxMed Released Research Data of "FAK inhibitor IN10018 overcomes drug resistance of KRAS G12C inhibition" at 2020 AACR Annual Meeting

SHANGHAI, June 24, 2020 /PRNewswire/ -- InxMed (Shanghai) Co., Ltd. ("InxMed" or "Company"), a clinical stage biotech company dedicated to developing innovative, individualized medicines with international impact, announced that the company has released the research data of "FAK inhibitor IN10018...

2020-06-24 08:41 299

The Taiwan External Trade Development Council launches online "Anti-COVID-19 Pavilion" sharing epidemic prevention information

HANOI, Vietnam, June 24, 2020 /PRNewswire/ -- In Jun 2020, The Taiwan External Trade Development Council (TAITRA) has announced the launch of the "Taiwan Anti-COVID-19 Pavilion." The pavilion combines the work of experts from different areas, including more than 20 medical institutions and 2,000...

2020-06-24 08:00 653

IgNova Files Patent Application on Antibody Against COVID-19

VISBEK, Germany, June 24, 2020 /PRNewswire/ -- IgNova announced today that it has filed a patent application covering the use of passive immunization to control SARS-CoV-2 infection in humans. IgNova, a biopharmaceutical R&D start up, researches technology based on specific egg immunoglobulins (I...

2020-06-24 02:13 732

Wolters Kluwer CCH Tagetik inTouch Online Conference Inspires CFOs to Evolve NOW with Solutions for Today and for a Future of Accelerated Financial Transformation

Global virtual event gathered the CCH Tagetik community to share key innovations, best practices and a vision of evolution in the Office of Finance through explainable and actionable data for faster, better-informed decision-making STAMFORD, Connecticut and LUCCA, Italy, June 23, 2020 /PRNewswir...

2020-06-23 20:00 3437

From Dustbags to Respiratory Protection in Electrolux Swedish Factory

STOCKHOLM, June 23, 2020 /PRNewswire/ -- The ongoing corona pandemic has created great global demand for respiratory protection. Electrolux's factory in Sweden, which manufactures vacuum cleaner bags, is now quickly switching parts of its operations to be able to produce at least one million face ...

2020-06-23 16:28 5020

Collinson Sets New Airport Lounge Standards in Health and Digital to Spearhead the Safe, Contactless Journey

* Helping to boost traveller confidence and drive a safe and effective recovery for the travel sector post-COVID-19, Collinson introduces a trio of airport lounge initiatives * Collinson's new set of global health and safety standards for airport lounges in the Priority Pass network will furt...

2020-06-23 14:20 551

Dymax Introduces MD(R) 250-CTH Cationic Epoxy for Medical Device Assembly

TORRINGTON, Conn., June 23, 2020 /PRNewswire/ -- Dymax Corporation expands its range of MD® Medical Device Adhesives with the introduction of MD® 250-CTH, a new cationic epoxy. It's formulated for manufacturers that require extremely low shrinkage for lens alignment and cementing of endoscope/mic...

2020-06-23 09:30 610

Greater cfDNA Recovery May Help Accelerate Development of Cancer Liquid Biopsy Applications

HONG KONG, June 23, 2020 /PRNewswire/ -- PHASE Scientific, a high-growth biotechnology company that develops innovative sample preparation technologies, announced new findings at the American Association for Cancer Research (AACR) 2020 Virtual Annual Meeting II. The study presented by MD Anderson...

2020-06-23 09:00 645

Bendit Technologies Announces Senior Management Appointments

Richard Cappetta has been appointed Chairman of the Board and Yossi Mazel will be the new CEO TEL AVIV, Israel, June 23, 2020 /PRNewswire/ -- Bendit Technologies, an industry leader in the development of steerable microcatheters, announced today thatRichard Cappetta has been appointed as its Cha...

2020-06-23 08:00 640

ABM Therapeutics Announces First Patient Dosed in Phase 1 Clinical Trial of ABM-1310 in the USA

SAN DIEGO, June 22, 2020 /PRNewswire/ -- ABM Therapeutics, a clinical-stage biopharmaceutical company developing a new generation of BRAF inhibitor, today announced that the first cancer patient has been successfully enrolled and dosed with ABM-1310 in the Phase 1 clinical trial in theUSA. ABM-13...

2020-06-22 23:00 511

New SEMI-NBMC, GE Research Project to Advance Vital Signs Monitoring of Patients During Emergency Air Transport

MILPITAS, California, June 22, 2020 /PRNewswire/ -- Nano-Bio Materials Consortium (NBMC), a SEMI Strategic Association Partner, today launched a project with GE Research to develop a medical-grade wireless patch that monitors the vital signs of medical patients during emergency air transport. Th...

2020-06-22 22:00 749

Greater cfDNA Recovery May Help Accelerate Development of Cancer Liquid Biopsy Applications

GARDEN GROVE, Calif. , June 22, 2020 /PRNewswire/ -- PHASE Scientific, a high-growth biotechnology company that develops innovative sample preparation technologies, announced new findings at the American Association for Cancer Research (AACR) 2020 Virtual Annual Meeting II. The study presented by...

2020-06-22 21:00 440

WAT Medical Delivers 650,000 Digital Thermometers to Canadian Customers

VANCOUVER, BC, June 22, 2020 /PRNewswire/ -- WAT Medical received an order for 650,000 digital thermometers from partners inCanada earlier this year. As of June, WAT Medical has finished manufacturing and delivering all of the requested units in a timely manner, while satisfying all of the specif...

2020-06-22 21:00 365

New Cynosure Global Report Reveals Strong Consumer Appetite For Return to In-Office Aesthetic Treatments

"The Return of Aesthetic Patients Post COVID-19" report finds majority of consumers eager to resume treatments and suggests necessary practitioner steps to ensure patient confidence WESTFORD, Massachusetts, June 22, 2020 /PRNewswire/ -- Cynosure, a global leader in medical aesthetics, today unve...

2020-06-22 20:45 472

Fluidra Presents a Unique Project That Combines All Recommended Anti-COVID-19 Measures in One Swimming Pool

BARCELONA, Spain, June 22, 2020 /PRNewswire/ -- Fluidra, global leader in the pool and wellness equipment business, presented the "Perfect COVID-FREE Pool" project at the Club Natació Atlètic-Barceloneta (CNAB) featuring measures which maximize safety, making them the safest pools against the cor...

2020-06-22 16:00 596

Spielwarenmesse eG Asks Trade and Industry About the Crisis

- Current mood among visitors and exhibitors - Creating new work models and communication channels NUREMBERG, Germany, June 22, 2020 /PRNewswire/ -- The Spielwarenmesse in Nuremberg attracts around 65,000 buyers and retailers and 2,800 manufacturers every year. To gauge how they are dealing with...

2020-06-22 16:00 531

Arçelik Completes Mass Production of 5,000 Ventilators to Meet International Demand

- Arçelik, which owns Beko and Grundig, collaborated with leading Turkish businesses to produce the life-saving ventilators on a not-for-profit basis - Ventilators have been provided to countries including Brazil, Chad, Nigeria, Niger, Azerbaijan, Libya, Uzbekistan, Somalia, Dagestan and Syria - ...

2020-06-22 16:00 547

Cutting-edge Multidisciplinary Approaches to Minimally Invasive Cancer Treatment Utilizing JCI MN COLLOIDAL IODINE (R) and Possible Effect on SARS-CoV-2

TOKYO, June 22, 2020 /PRNewswire/ -- On June 10, 2020, JCI MN IODINE Co., Ltd. released the following new information regarding the therapeutic usefulness of JCI MN IODINE agents.Ryusuke Fujiki, Clinical Head and President of Fujiki Hospital, announced "minimally invasive, multidisciplinary treat...

2020-06-22 13:00 313

Kazia Presents Further Paxalisib and Cantrixil Data at AACR, Reinforcing Positive Efficacy Signals for both Drugs

SYDNEY, June  22, 2020 /PRNewswire/ -- Kazia Therapeutics Limited (ASX: KZA; NASDAQ: KZIA), an Australian oncology-focused biotechnology company, is pleased to share poster presentations of interim data from the ongoing phase II study of paxalisib (formerly GDC-0084) in glioblastoma, the most com...

2020-06-22 12:39 2994
1 ... 45678910 ... 854